Chie Nishioka

AZD1152, a novel and selective aurora B kinase inhibitor, induces growth arrest, apoptosis, and sensitization for tubulin depolymerizing agent or topoisomerase II inhibitor in human acute leukemia cells in vitro and in vivo

Jing Yang, Takayuki Ikezoe, Chie Nishioka et al. · Blood · 2007 · 286 citations · Full text

Medicine, Oncology, Pharmacology +17

Isolation and partial characterization of a noval amino sugar-containing fucan sulfate from commercial Fucus vesiculosus fucoidan

Takashi Nishino, Chie Nishioka, Hiroaki Ura et al. · Carbohydrate Research · 1994 · 153 citations

Life Sciences, Biochemistry, Microbiology +10

A novel treatment strategy targeting Aurora kinases in acute myelogenous leukemia

Takayuki Ikezoe, Jing Yang, Chie Nishioka et al. · Molecular Cancer Therapeutics · 2007 · 131 citations · Full text

Medicine, Cancer Biology, Oncology +14

Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells

Takayuki Ikezoe, Chie Nishioka, Kentaro Bandobashi et al. · Leukemia Research · 2006 · 107 citations · Full text

Life Sciences, Oncology, Pharmacology +14

The antitumor effects of sunitinib (formerly SU11248) against a variety of human hematologic malignancies: enhancement of growth inhibition via inhibition of mammalian target of rapamycin signaling

Takayuki Ikezoe, Chie Nishioka, Taizo Tasaka et al. · Molecular Cancer Therapeutics · 2006 · 101 citations · Full text

Medicine, Oncology, Pharmacology +17